Gadi Lachman, TriNetX Founder, Joins Srotas Health Board to Advance AI-Driven Clinical Trial Recruitment
核心洞察
Gadi Lachman, founder and former CEO of TriNetX (搜索), has been appointed to the Board of Directors of AI health tech company Srotas Health (搜索).
Srotas Health (搜索) has developed a proprietary Agentic AI platform that automates the full clinical trial patient recruitment execution layer, built with over 50 clinicians across three years.
The platform is live across more than 50 research sites in the US and UK, supporting over 60 active clinical trials and processing more than three million patient records.
SAN FRANCISCO, June 30, 2026 — Srotas Health (搜索), an AI health technology company focused on streamlining clinical trial recruitment, feasibility, and patient engagement, announced the appointment of Gadi Lachman to its Board of Directors. Lachman is the founder and former CEO of TriNetX (搜索), the global infrastructure connecting healthcare organizations, biopharma companies, and researchers across 19 countries.
Suman Bhaskaran and Vikram Parimi, Co-founders of Srotas Health (搜索), described Lachman as "the architect of the global clinical research data infrastructure, the networks, the connections, and the systems that the entire industry runs on today." They added: "He has spent over a decade at the centre of this world. He has seen every technology, every promise, and every company that claimed to solve patient recruitment. He chose Srotas Health. That says more about what we have built than anything we could ever say ourselves."
The Stagnation of Clinical Trial Recruitment
The announcement highlights a persistent challenge in clinical research: the patient recruitment process has remained largely unchanged for seven decades. In 1954, the Salk polio trial enrolled 1.8 million children using 300,000 volunteers coordinating across 44 states with nothing but paper forms and telephone calls. According to Srotas Health (搜索), clinical research sites today are still finding and enrolling patients using fundamentally the same approach, even as the underlying science has transformed medicine.
A Proprietary Agentic AI Approach
Srotas Health (搜索) positions itself as the only Agentic AI platform in clinical research that owns the full recruitment execution layer. Unlike competitors that rely on generic third-party AI APIs for sensitive clinical workflows involving patient data, the company runs on proprietary clinical large language models developed in-house. These models were built through three years of clinician-led development involving more than 50 clinicians and evaluated across millions of real-world patient records. Clinical evidence supporting the platform is available on MedRxiv.
The platform operates on a HIPAA and GDPR compliant infrastructure, ensuring patient data never leaves the client's environment. It is currently live across more than 50 research sites in the United States and the UK, supporting over 60 active clinical trials, with more than three million patient records processed to date.
Measurable Impact on Recruitment
Research sites using the Srotas Health (搜索) platform have seen a 60% increase in patient recruitment compared to their previous methods, according to the company.
Gadi Lachman commented on his appointment: "I am honoured to join the Srotas Health (搜索) journey at such an exciting moment. Applying AI to solve the last mile of patient recruitment for clinical trials is one of the most pragmatic and valuable implementations of AI I have seen in the pharma and real-world data space. This is a truly meaningful contribution to clinical research, and ultimately great news for patients."
Srotas Health (搜索) is backed by Innovate UK, SFC Capital, Clarendon Fund Managers, and Invest NI, with operations across the United States and the UK. The company serves pharmaceutical companies, CROs, and clinical research sites seeking to automate patient recruitment end-to-end workflows.